PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK.\', \'Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.\', \'National infection Service, Public Health England, Porton Down, Salisbury, SP4 OJG, UK.\', \'Cancer Research UK Clinical Trials Unit, University of Birmingham, B15 2TT, Birmingham, UK.\', \'St. James\'s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.\', \'Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, B15 2TH, UK.\', \'Birmingham Heartlands Hospital, University Hospitals Birmingham, Bordesley Green East, B9 5SS, Birmingham, UK.\', \'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK. P.moss@bham.ac.uk.\', \'Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, B15 2TH, UK. P.moss@bham.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41408-021-00528-x
?:doi
?:hasPublicationType
?:journal
  • Blood cancer journal
is ?:pmid of
?:pmid
?:pmid
  • 34330895
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.727
?:rankingScore_hIndex
  • 30
?:title
  • Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34330895>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34330895>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all